Using these biomarker validation steps, features including high-grade prostatic intraepithelial neoplasia (HGPIN), PSA level, apoptosis and proliferation may be considered as surrogate endpoint biomarkers of PCa [100]. This evidence concerns the gene PROS1 and posterior cortical atrophy.